Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
- PMID: 34942956
- PMCID: PMC8699589
- DOI: 10.3390/brainsci11121654
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
Abstract
The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since 2020. Links between the newly discovered viral infection and the pathogenesis of neurodegenerative diseases have been investigated in different studies. This review aims to summarize the literature concerning COVID-19 and Parkinson's disease (PD) to give an overview on the interface between viral infection and neurodegeneration with regard to this current topic. We will highlight SARS-CoV-2 neurotropism, neuropathology and the suspected pathophysiological links between the infection and neurodegeneration as well as the psychosocial impact of the pandemic on patients with PD. Some evidence discussed in this review suggests that the SARS-CoV-2 pandemic might be followed by a higher incidence of neurodegenerative diseases in the future. However, the data generated so far are not sufficient to confirm that COVID-19 can trigger or accelerate neurodegenerative diseases.
Keywords: Alzheimer’s disease; COVID-19; Parkinson’s disease; SARS-CoV-2; neurodegeneration; viral infection.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease.Front Cell Neurosci. 2021 Jun 15;15:670298. doi: 10.3389/fncel.2021.670298. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34211370 Free PMC article. Review.
-
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.J Neural Transm (Vienna). 2022 Sep;129(9):1155-1167. doi: 10.1007/s00702-022-02500-w. Epub 2022 Apr 17. J Neural Transm (Vienna). 2022. PMID: 35434769 Free PMC article. Review.
-
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.Oxid Med Cell Longev. 2022 Aug 31;2022:3012778. doi: 10.1155/2022/3012778. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36092161 Free PMC article. Review.
-
Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.Int J Mol Sci. 2022 Aug 28;23(17):9739. doi: 10.3390/ijms23179739. Int J Mol Sci. 2022. PMID: 36077138 Free PMC article. Review.
-
Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.Transl Neurodegener. 2023 Jan 30;12(1):5. doi: 10.1186/s40035-023-00337-1. Transl Neurodegener. 2023. PMID: 36717892 Free PMC article. Review.
Cited by
-
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.Molecules. 2022 Jun 28;27(13):4142. doi: 10.3390/molecules27134142. Molecules. 2022. PMID: 35807384 Free PMC article. Review.
-
SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.Cell Rep Med. 2024 May 21;5(5):101570. doi: 10.1016/j.xcrm.2024.101570. Epub 2024 May 14. Cell Rep Med. 2024. PMID: 38749422 Free PMC article.
-
Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?Biomedicines. 2023 Feb 9;11(2):498. doi: 10.3390/biomedicines11020498. Biomedicines. 2023. PMID: 36831034 Free PMC article.
-
Möglicher Einfluss von Viren auf die Ausbreitung von Proteinaggregaten.Biospektrum (Heidelb). 2022;28(2):162-164. doi: 10.1007/s12268-022-1730-9. Epub 2022 Mar 28. Biospektrum (Heidelb). 2022. PMID: 35369113 Free PMC article. Review. German.
-
Comment on "The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging".Rev Assoc Med Bras (1992). 2022 Nov 28;68(12):1624-1625. doi: 10.1590/1806-9282.20221201. eCollection 2022. Rev Assoc Med Bras (1992). 2022. PMID: 36449811 Free PMC article. No abstract available.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous